A GROWTH FACTOR CONCENTRATE FOR TREATING FACIAL WRINKLES

摘要

The invention relates to an intra-dermally, sub-dermally or topically administrable growth factor concentrate derived from approximately 250 x 106 to 5000 x 106 human platelets per ml for treating facial wrinkles. The concentrate comprises approximately 900 to 2000 pg/ml of Epidermal growth factor (EGF), 30 to 300 pg/ml of Vascular Endothelial growth factor(VEGF), 20 to 100 pg/ml of Basic fibroblast growth factor (b-FGF), 40000 to 120000 pg/ml of Transforming growth factor-β(TGF-β) and 200000 to 600000 pg/ml of Platelet Derived growth factor-AB (PDGF-AB).